MERCK & CO INC (NYSE: MRK)

Overview
current price
$86.23
$86.23
change
4.69 | 5.75%
4.69 | 5.75%
Yesterday's Close
81.54
open
83.38
volume
23.62 M
30d. avg volume.
18.28 M
1 day
83.17 - 86.80
52 weeks
68.29 - 84.56
p/e
29.33
beta
0.4053
market cap
206.41 B
dividend yield
3.19%
Industry
-
News and Commentary
Merck Seeks Approval for First Pill To Treat COVID-19
Big Pharma Buyout: Merck to Buy Acceleron for $11.5 Billion Merck & Co. (MRK 
Merck's Oral COVID Antiviral Reduces Risk of Hospitalization or Death by About 50% Pharmaceutical giant Merck & Co (
Market Update: Stocks Rally Higher on Merck COVID Antiviral Drug Optimism Stocks rose higher on Friday as investors looked past a rough September as positive COVID treatment news boosted economic recovery names. However, even with the day's rally, the...
IPO Market Continues Record Pace with 18 Listings Last Week The initial public offering (IPO) market continued at its red hot pace last week with 18 traditional IPOs listing on U.S. markets, marking the fourth week this year with at least...
Executives Gather to Discuss Voting Restrictions Dozens of executives, including current and former CEOs and other senior-level corporate leaders, gathered in a Zoom
U.S. to Make All Adults Eligible for COVID Vaccines by May 1 In his first primetime address, President Joe Biden announced that he has directed states to make all adults, ages 18 and up, eligible for the coronavirus vaccine by May 1. Biden...
Biden Says U.S. Will Have Enough Vaccine Doses For Every Adult in May President Joe Biden announced on Tuesday that the United States has now secured enough vaccine doses for every adult in the country to be fully vaccinated by the end of May.
Merck & Co Terminates COVID Vaccine Program Health firm Merck & Co (MRK
Regeneron Antibody Therapy Showing Promise A coronavirus antibody treatment being tested by Regeneron
StockTwits
StockTwits

Join now and unlock premium features